Log In
Print
BCIQ
Print
Print this Print this
 

IT-139 (formerly NKP-1339)

  Manage Alerts
Collapse Summary General Information
Company Intezyne Technologies Inc.
DescriptionTransferrin targeted ruthenium-based small molecule that downregulates GRP78
Molecular Target Heat shock 70 kDa protein 5 (glucose-regulated protein, 78kDa) (HspA5) (GRP78)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today